肝炎康对大鼠慢性肝纤维化的保护作用(2)
 |
综上所述，肝炎康CCl4 所致慢性肝纤维化保具有护和治疗作用，其作用机制可能与抑制脂质过氧化和抑制胶原合成等有关。
参考文献
1 肝脏病学会肝纤维化学组.肝纤维化诊断及疗效评估共识.中华肝脏病杂志,2002,10(5):327-328.
2 Friedman SL.Hepatic fibrosis in:Schiff ER,Sorrell MF,Maddrey WC,et al.Schiffs Diseases of Liver.Philadelphia:Lippncott - Raven,1999:371-386.
3 王英凯，迟宝荣，孙波，等.肝硬化大鼠模型的建立及其稳定性.吉林大学学报(医学版),2005,31(6):893- 896.
4 Sarem M,Znaidak R,Macias M,et al.Hepatic stellate cells:it's role in normal and pathological conditions.Gastroenterol Hepatol,2006,29:93-101.
5 Shi J,Aisaki K,lkawa Y,et al.Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride.Am J Pathol,1998,153:515-525.
6 Sim AS,Salonikas C,Naidoo D,et al.Improved method for plasma malondialdehyde measurement by high-performance liquid chromatography using methyl malondialdehyde as an internal standard.J Chromatogr B Analyt Technol Biomed Life Sci,2003,785:337-344.
7 Khoschsorur GA,Winklhofer-Roob BM,Rabl H,et al.Evaluation of a sensitive HPLC method for the determination of malondialdehyde,and application of the method to different biological materials.Chromatographia,2000,52:181-184.
8 Popper H,Kent G.Fibrosis in chronic liver disease.C lin Gastroenterol,1975,4(2):315-332., http://www.100md.com(李迎春 陈 洁)